YD Bio Limited Ordinary Shares (YDES)
Automate Your Wheel Strategy on YDES
With Tiblio's Option Bot, you can configure your own wheel strategy including YDES - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol YDES
- Rev/Share 0.0
- Book/Share -4.7076
- PB -1.8417
- Debt/Equity 0.0
- CurrentRatio 0.0171
- ROIC 0.1668
- MktCap 611420183.0
- FreeCF/Share -0.3449
- PFCF -519.9947
- PE -9.9373
- Debt/Assets 0.0
- DivYield 0
- ROE 0.283
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
Published: October 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
Taipei, Taiwan, Oct. 20, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (NasdaqGM: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today rang the Opening Bell at Nasdaq MarketSite in New York to celebrate its public listing on the Nasdaq Global Market. This milestone strengthens YD Bio's capital base, elevates its global profile and accelerates the commercialization of its next-generation diagnostic and regenerative medicine platforms.
Read More
About YD Bio Limited Ordinary Shares (YDES)
- IPO Date 2025-08-29
- Website https://www.ydesgroup.com
- Industry Biotechnology
- CEO Ethan Shen
- Employees 4